“Aitingjiu (Dapoxetine Hydrochloride Tablets)” applies to the treatment of male patients with premature ejaculation (PE), which is the first ’’Drug Registration Approval Document’’ issued by the National Medical Products Administration (NMPA) through consistency evaluation.  Dapoxetine hydrochloride is the first drug approved by NMPA for the treatment of premature ejaculation and is also the preferred drug recommended in Chinese Guidelines for Diagnosis and Treatment of Andrology Diseases and Expert Consensus on Premature Ejaculation.

SFDA approval number: H20203169

You are welcome to contact me for the product instruction manual and other relevant information.